Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.585
+0.015 (0.58%)
At close: Apr 28, 2026, 4:00 PM EDT
2.590
+0.005 (0.19%)
After-hours: Apr 28, 2026, 4:04 PM EDT
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $327.17 million as of April 28, 2026. Its market cap has increased by 250.71% in one year.
Market Cap
327.17M
Enterprise Value
254.41M
1-Year Change
250.71%
Ranking
Category
Stock Price
$2.59
Market Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has increased from $117.04M to $327.17M, an increase of 179.55%. That is a compound annual growth rate of 22.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 325.27M | 32.07% |
| Dec 31, 2025 | 246.29M | 16.76% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Surrozen | 344.03M |
| Rezolute | 343.82M |
| DiaMedica Therapeutics | 340.54M |
| Bicycle Therapeutics | 332.50M |
| Greenwich LifeSciences | 332.37M |
| Palisade Bio | 328.15M |
| Cabaletta Bio | 323.95M |
| Compass Therapeutics | 322.36M |